Western blot and immunohistochemistry analysis revealed a significant reduction in the levels of CaMKK2 and phosphorylated AMPK (p-AMPK) in the livers of mice from the NAFLD group. This evidence concerns the gene CAMKK2 and metabolic dysfunction-associated steatotic liver disease.